Author

E. D. Muse

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Henke· 1 shared C. K. Glass· 1 shared C. R. Edillor· 1 shared D. E. Webster· 1 shared D. Wing· 1 shared E. Ashley· 1 shared J. Bahadorani· 1 shared J. G. McDonald· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Henke

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Heart Snapshot: a broadly validated smartphone measure of VO2max for collection of real world data

D. E. Webster, M. Tummalacherla, M. Higgins, D. Wing, E. Ashley, V. E. Kelly, M. V. McConnell, E. D. Muse, J. Olgin, L. Mangravite, J. Godino, M. Kellen, L. Omberg

This paper develops and validates a smartphone-based method to estimate VO2max using a 3-minute step test, showing high reliability and minimal bias across diverse populations.

bioRxiv · Jul 2, 2020 · PreprintBioengineering

Cell-specific discrimination of desmosterol and desmosterol mimetics confers selective regulation of LXR and SREBP pathways in macrophages

E. D. Muse, S. Yu, C. R. Edillor, J. Tao, N. J. Spann, T. D. Troutman, J. S. Seidman, A. Henke, J. T. Roland, K. A. Ozeki, J. G. McDonald, J. Bahadorani, S. Tsimikas, T. R. Grossman, M. S. Tremblay, C. K. Glass

This study shows that desmosterol and its mimetics selectively activate LXR in macrophages without inducing SREBP1c-mediated hypertriglyceridemia, unlike conventional LXR agonists.

bioRxiv · Feb 11, 2018Cell Biology